1. Yelemkoure, E.T., A.T. Yonli, H.K. Sombie, I. Tao and A.A. Zoure et al., 2022. Seroprevalence, genotyping, and monitoring of hepatitis C viral loads in patients on antivirals in Burkina Faso. Intervirology, 65: 151-159.
   CrossRef  |  Direct Link  |  
2. Tovo, S.F., T.M. Zohoncon, A.M. Dabire, R. Ilboudo and R.Y. Tiemtore et al., 2021. Molecular epidemiology of human papillomaviruses, Neisseria gonorrhoeae, Chlamydia trachomatis and Mycoplasma genitalium among female sex workers in Burkina Faso: Prevalence, coinfections and drug resistance genes. Trop. Med. Infect. Dis., Vol. 6. 10.3390/tropicalmed6020090.
   CrossRef  |  Direct Link  |  
3. Sombie, H.K., D. Tchelougou, A.K. Ouattara, J.K. Kologo and P.A. Sorgho et al., 2021. Glutathione S-transferase M1 and T1 genes deletion polymorphisms and blood pressure control among treated essential hypertensive patients in Burkina Faso. BMC Res. Notes, Vol. 14. 10.1186/s13104-021-05658-w.
   CrossRef  |  Direct Link  |  
4. Minoungou, G.L., M. Diop, M. Dakouo, A.K. Ouattara and T.B.K. Settypalli et al., 2021. Molecular characterization of African Swine fever viruses in Burkina Faso, Mali, and Senegal 1989-2016. Transbound. Emerg. Dis., 68: 2842-2852.
   CrossRef  |  Direct Link  |  
5. Millogo, M., S.T. Soubeiga, B.V.J.T. Bazie, T.M. Zohoncon, A.K. Ouattara, A.T. Yonli and J. Simpore, 2021. Disputed paternity presumption in Burkina Faso: Determination of the biological fathers of children using ABO-rhesus/hemoglobin electrophoresis and STR assays. J. Genet. Eng. Biotechnol., Vol. 19. 10.1186/s43141-021-00221-3.
   CrossRef  |  Direct Link  |  
6. Wongjarupong, N., A.T. Yonli, B.M. Nagalo, F.W. Djigma and S.K. Somda et al., 2020. Characteristics of patients with chronic hepatitis B virus infection with genotype E predominance in Burkina Faso. Hepatol. Commun., 4: 1781-1792.
   CrossRef  |  Direct Link  |  
7. Ouedraogo, S.Y., D. Tchelougou, J.K. Kologo, H.K. Sombie and M.M.J. Zeye et al., 2020. No correlation between the variants of exostosin 2 gene and type 2 diabetes in Burkina Faso population. J. Public Health Afr., 11: 59-61.
   CrossRef  |  Direct Link  |  
8. Yooda, A.P., S. Sawadogo, S.T. Soubeiga, D. Obiri-Yeboah and K. Nebie et al., 2019. Residual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina Faso. J. Blood Med., 10: 53-58.
   CrossRef  |  Direct Link  |  
9. Compaore, T.R., S.T. Soubeiga, A.K. Ouattara, D. Tchelougou and C. Bisseye et al., 2018. APOBEC3G expression and HIV-1 infection in Burkina Faso. J. Public Health Afr., 9: 159-161.
   CrossRef  |  Direct Link  |  
10. Ouattara, A.K., P. Yameogo, L. Traore, B. Diarra and M. Assih et al., 2017. Prevalence, genetic variants and clinical implications of G-6-PD deficiency in Burkina Faso: A systematic review. BMC Med. Genet., Vol. 18. 10.1186/s12881-017-0496-2.
    CrossRef  |  Direct Link  |